Skip to main content
. 2021 Jun 8;12(4):1056–1063. doi: 10.1002/jcsm.12739

Table 1.

Patients' characteristics

HG COVIDG COPDG HDG P value
Age (years) 52.2 (4.9) 54.6 (9.1) 56.9 (7.1) 54.4 (8.5) 0.369
Men (%) 100 100 100 100
Body mass Index (kg/m2) 24.2 (3.5) 29.1 (4.4) 28.3 (6.51) 28.2 (4.0) 0.552
Adjusted morbidity groups (%) <0.001
Basal risk 100% 33.3% 0% 0%
Low risk 0% 46.6% 13.3% 6.6%
Moderate risk 0% 13.4% 53.3% 46.7%
High risk 0% 6.7% 26.7% 46.7%
Very high risk 0% 0% 6.7% 0%
FVC (L) 5.1 (1.1) 3.8 (1.1) 2.7 (0.7) 4.1 (0.8) 0.007
FVC (%) 103.2 (15.8) 87.3 (17.1) 68.3 (15.2) 87.2 (9.7) 0.002
FEV1 (L) 3.9 (0.8) 3.1 (0.8) 1.4 (0.6) 3.2 (0.8) <0.001
FEV1 (%) 102.2 (17.7) 88.1 (24.1) 48.1 (21.1) 87.9 (15.1) <0.001
FEV1/FVC, % 79.9 (7.4) 82 (6.3) 53.3 (16.6) 77.2 (9.1) <0.001

COPDG, chronic obstructive pulmonary disease group; COVIDG, COVID‐19 group; FEV1, forced expiratory volume in the first second; FVC, forced vital capacity; HDG, heart disease group; HG, healthy group; SD, standard deviation.